Physician profile
Bryan Costin
NPI 1871732206
$624.63
in general payments reported to CMS, 2019-2025
10 companies · $35.35 in 2025
The $35.35 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $146 · 2021: $241 · 2022: $35.64 · 2024: $41.92 · 2025: $35.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $227.40 | 2021 | |
| Ocular Therapeutix, INC. | $146.48 | 2020 | |
| Revance Therapeutics, INC. | $77.27 | 2024-2025 | Daxxify |
| Medline Industries LP | $48.08 | 2019 | |
| Sight Sciences, INC. | $47.79 | 2019 | |
| Abbvie INC. | $19.56 | 2022 | |
| Shire North American Group INC | $16.94 | 2019 | |
| Galderma Laboratories, L.P. | $16.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.09 | 2021 | |
| Horizon Therapeutics Plc | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Costin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.